Q1 2024 Holdings
Filed 2024-05-15 | 34 holdings | $2.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $313.7M | 4,177,830 | 11.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $265.5M | 3,818,095 | 9.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $217.4M | 552,120 | 7.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $148.8M | 2,389,902 | 5.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $146.3M | 3,124,749 | 5.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $139.6M | 1,078,346 | 4.9% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $116.2M | 1,787,176 | 4.1% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $111.2M | 1,982,006 | 3.9% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $107.9M | 2,614,935 | 3.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $107.0M | 2,484,874 | 3.8% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $104.1M | 2,863,406 | 3.7% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $98.5M | 2,330,508 | 3.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $93.9M | 2,914,975 | 3.3% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $89.5M | 7,903,600 | 3.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $88.1M | 5,031,420 | 3.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $84.7M | 1,239,995 | 3.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $84.1M | 2,121,163 | 3.0% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $80.8M | 3,246,759 | 2.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $76.8M | 507,952 | 2.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $66.9M | 3,135,387 | 2.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $44.6M | 2,446,373 | 1.6% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $41.0M | 6,425,803 | 1.4% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $36.3M | 2,233,610 | 1.3% |
| Immatics N.v(IMTX) | SHS | N44445109 | $29.6M | 2,818,908 | 1.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $25.8M | 799,054 | 0.9% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $23.0M | 1,348,015 | 0.8% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $21.9M | 330,000 | 0.8% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $19.9M | 2,390,988 | 0.7% |
| VOR Biopharma Inc | COM | 929033108 | $15.3M | 6,457,293 | 0.5% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $14.9M | 944,917 | 0.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $11.7M | 400,000 | 0.4% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $11.2M | 2,172,620 | 0.4% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $3.3M | 147,959 | 0.1% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $1.2M | 50,000 | 0.0% |